Additionally, a cerebral ischemia reperfusion model, similarly to recanalization therapy, demonstrated that microbiota from young mice may inhibit interleukin-17 production and lower reperfusion injury in aged mice [54]. The gene discussed is IL17A; the disease is Cerebral ischemia.